DRUG ACCUMULATION AND DNA PLATINATION IN CELLS EXPOSED TO AQUATED CISPLATIN SPECIES

被引:17
作者
JENNERWEIN, M [1 ]
ANDREWS, PA [1 ]
机构
[1] GEORGETOWN UNIV,DEPT PHARMACOL,WASHINGTON,DC 20007
关键词
CISPLATIN; DRUG TRANSPORT; HUMAN OVARIAN CARCINOMA;
D O I
10.1016/0304-3835(94)90205-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Since CP always exists in aqueous solution as a mixture of native drug and various aqua and hydroxo species, it is conceivable that one or more of these aquated species is the main form of the drug that enters the cell. To test this hypothesis, we examined the accumulation by 2008 human ovarian carcinoma cells of CP and aquated CP in Cl-, deficient medium. After 24 h in 150 mM NaNO3, HPLC analysis indicated that 54% of the platinum in solution was accounted for by aquated species. Immediately following addition of this solution to Cl- deficient RPMI 1640 medium, the initial concentrations of the aqua and hydroxo species were calculated to be 34-2400-fold higher with preaquated CP than with native CP. The cellular platinum accumulation, however, was the same under both conditions and was also identical to that of native CP in normal RPMI. To confirm that aquated species were actually entering the cell, the amount of platinum reaching the DNA was determined. The total platinum levels on DNA were 1.9-fold higher when cells were exposed to pre-aquated CP in Cl- deficient medium compared to CP in regular medium. We conclude that 2008 cells do not preferentially transport an aquated form of CP under these conditions compared to native CP.
引用
收藏
页码:215 / 220
页数:6
相关论文
共 28 条
[1]  
ANDREWS PA, 1990, CANCER CELL-MON REV, V2, P35
[2]  
ANDREWS PA, 1991, CANCER RES, V51, P3677
[3]  
ANDREWS PA, 1988, PLATINUM OTHER METAL, P248
[4]  
BASOLO F, 1967, MECHANISMS INORGANIC, P351
[5]  
BASU A, 1990, J BIOL CHEM, V265, P8451
[6]   HYDROLYSIS PRODUCTS OF CISPLATIN - PKA DETERMINATIONS VIA [H-1, N-15] NMR-SPECTROSCOPY [J].
BERNERSPRICE, SJ ;
FRENKIEL, TA ;
FREY, U ;
RANFORD, JD ;
SADLER, PJ .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1992, (10) :789-791
[7]   KINETICS AND MECHANISM OF UPTAKE OF PLATINUM-BASED PHARMACEUTICALS BY THE RAT SMALL-INTESTINE [J].
BINKS, SP ;
DOBROTA, M .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (06) :1329-1336
[8]   CHARACTERIZATION OF THE REACTIONS OF PLATINUM ANTITUMOR AGENTS WITH BIOLOGIC AND NONBIOLOGICAL SULFUR-CONTAINING NUCLEOPHILES [J].
DEDON, PC ;
BORCH, RF .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (12) :1955-1964
[9]   DECREASED CISPLATIN UPTAKE BY RESISTANT L1210 LEUKEMIA-CELLS [J].
HROMAS, RA ;
NORTH, JA ;
BURNS, CP .
CANCER LETTERS, 1987, 36 (02) :197-201
[10]  
ISONISHI S, 1991, CANCER RES, V51, P5903